Application 021424
- Type
- NDA
- Sponsor
- PARKE DAVIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEURONTIN | GABAPENTIN | SOLUTION; ORAL | 250MG/5ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | Exelan Pharmaceuticals, Inc. | a88edb00-2189-4c8d-9dd7-9fe1571775cc | 2025-08-16 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | XLCare Pharmaceuticals, Inc. | 707ed63a-67ca-4a62-9cbe-cdeb5c4ab506 | 2025-08-16 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | XLCare Pharmaceuticals, Inc. | 618c948d-deee-44e2-98f0-e5232171dd50 | 2025-08-04 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | ca8177ed-1f0d-436e-a5ac-f58b8f7cbb25 | 2025-07-28 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 2278ce1b-1c19-4ad2-89c6-4530f7b78ea7 | 2025-07-14 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | NorthStar Rx LLC | 9508cb1b-3f9f-48bd-8f34-a6fbb68c9a4a | 2025-07-11 | Warnings, Adverse reactions | GABAPENTIN |
| gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 3f2e3ac5-5233-fd57-e063-6294a90a849e | 2025-07-01 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 7c3b232a-3e9f-4249-9e5a-295482ee288a | 2025-06-27 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | NorthStar Rx LLC | f7c1fd34-d615-43a2-8989-898fe11f90df | 2025-06-25 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | d25daaac-a8ab-4f12-acc2-4ec8fc97a2d4 | 2025-06-24 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | QUALLENT PHARMACEUTICALS HEALTH LLC | 472bb279-bb4e-4246-b2a3-172483ba356b | 2025-06-23 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 5d3f27bf-3486-40fa-a4d3-5f0b2c6c0151 | 2025-06-11 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 561f53d5-5301-42b3-b372-f3d49d642a2e | 2025-06-11 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Direct_Rx | ed9c501c-24e4-da89-e053-2a95a90a64c6 | 2025-06-09 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 11645bd6-7cfe-49b2-9292-2e4b0dbb84ae | 2025-06-04 | Warnings, Adverse reactions | GABAPENTIN |
| gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | 969cccfc-e56a-49da-9d36-47c0c3fad7f8 | 2025-06-03 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | PAI Holdings, LLC dba PAI Pharma | 6d3fd1f9-c831-4262-af10-291838a53541 | 2025-05-31 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | 8215da86-d7af-4980-b6d6-4bd46f6bfeaf | 2025-05-30 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | ATLANTIC BIOLOGICALS CORP. | 5969f1a8-d6d5-4967-add5-4e2492354d7b | 2025-05-27 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | 0ce53f62-1738-43f4-9a2e-c5dc42a91d09 | 2025-05-26 | Warnings, Adverse reactions | GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.